ETA-DOC-0004·Compound index·Rev 1·Methodology v0.1Provisional — reviewer not yet appointed
compound index · M, page 4 of 5 · methodology v0.1 · reviewer not yet appointed
Compound index · M ETA-DOC-0004

Compound index — M

865 substances begin with M. 6 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, Mimulus Ringens Whole – Musa Acuminata Fruit.

US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Mimulus Ringens Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009656
Mineral enriched fungal biomass (Aspergillus oryzae) EU-NOVEL Not yet graded
Not novel in food
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-009657
Mineral Oil US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic alpha1-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Market presence131 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009658
Mineralwasser/ Calcium EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“[In german:] kräftigt die Nägel Clarification provided strengthens the nails.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009659
Mineralwasser/ Hydrogencarbonat (Bicarbonat) EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“[In german : ] ist zusammen mit Calcium für eine gute Knochendichte notwendig Clarification provided: Hydrogencarbonate from mineral water cares together with calcium for adequate bone density significantly”Non-authorisedArt.13(1)EFSA opinion
“[In german : ] kann die Muskelermüdung beim Ausdauersport verzögern Clarification provided can delay tiring of muscles in endurance sports”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009660
Mineralwasser/ Kieselsäure (Silizium) EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“[In german : ] stärkt/festigt das Bindegewebe Clarification provided –strengthens/stabilizes the connective tissue”Non-authorisedArt.13(1)EFSA opinion
“[In german : ] stärkt/festigt das Bindegewebe Clarification provided –strengthens/stabilizes the connective tissue”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009661
Mineralwasser/ Kohlensäure EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“[In german : ] regt die Verdauung an Clarification provided stimulates digestion”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009662
Mineralwasser/ Natriumchlorid EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“[In German:] zur Anregung des Appetits. Clarification provided To stimulate the appetite.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009664
Mineralwasser/Natrium- Hydrogencarbonat EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“[In german : ] gut für den Blutdruck Clarification provided supports regulation of blood pressure”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009663
Minocycline US-DRUG Not yet graded
US: anda
Class as recordedDecreased Prothrombin Activity [PE]; Tetracycline-class Drug [EPC]; Tetracyclines [CS]
Earliest US approval1971
Market presence156 US product listings · 41 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009665
Minoxidil US-DRUG Not yet graded
US: anda
Class as recorded5-alpha Reductase Inhibitor [EPC]; 5-alpha Reductase Inhibitors [MoA]; Allergens [CS]; Arteriolar Vasodilation [PE]
Earliest US approval1979
Market presence351 US product listings · 37 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009666
Mint US-DRUG Not yet graded
US: otc monograph drug
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009667
Mipomersen Sodium EU-MEDUS-DRUG Not yet graded
EU medicine: Refused
Class as recordedC10AX11
Earliest US approval2013
Market presence1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009668
Mirabegron EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAdrenergic beta3-Agonists [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; G04BD12
Earliest US approval2012
Market presence47 US product listings · 14 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009669
Mirabilitum praeparatum CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009670
Mirdametinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedKinase Inhibitor [EPC]; L01EE; Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]; Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]
Earliest US approval2025
Market presence4 US product listings · 2 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009671
Mirikizumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedInterleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]; L04AC
Market presence8 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009672
Mirikizumab-Mrkz US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009673
Miripirium Chloride US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009674
Mirobalanus embilica CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009675
Mirogabalin US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009676
Mirtazapine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Earliest US approval1996
Market presence162 US product listings · 26 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009677
Mirvetuximab US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009678
Mirvetuximab Soravtansine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedL01FX26
Market presence1 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009679
Mirvetuximab Soravtansine-Gynx US-DRUG Not yet graded
US: drug for further processing
Earliest US approval2022
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009680
Misoprostol US-DRUG Not yet graded
US: anda
Class as recordedAnti-Inflammatory Agents; Cyclooxygenase Inhibitors [MoA]; Decreased Prostaglandin Production [PE]; Non-Steroidal [CS]
Earliest US approval1988
Market presence63 US product listings · 13 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009681
Mitapivat EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedB06AX04; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]
Earliest US approval2022
Market presence7 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009682
Mitchella Repens CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence1 US product listings · 32 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009683
Mitochondria-Derived Peptide MOTS-C ETALYNUS-DRUG E/insufficientband 6
US: bulk ingredient
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009684
Mitomycin US-DRUG Not yet graded
US: anda
Class as recordedAlkylating Activity [MoA]; Alkylating Drug [EPC]
Earliest US approval1981
Market presence46 US product listings · 18 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009685
Mitotane EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCytochrome P450 3A4 Inducers [MoA]; L01XX23
Earliest US approval1970
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009686
Mitoxantrone Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedTopoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
Earliest US approval1987
Market presence5 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009687
Mitragyna speciosa CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009688
mitratapide EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQA08AB90
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009689
Mivacurium Chloride US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1992
Market presence2 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009690
Mix of Glucose-Fructose EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“helps to lower level of the consumed alcohol in the body by decelerating of the absorbin of alcohol”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009691
Mixed carotenoids CA-NHP Not yet graded
CA licensed ingredient
Market presence168 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009692
Mixed Natural Carotenoids CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009693
Mixed tocopherol concentrate CA-NHP Not yet graded
CA licensed ingredient
Market presence274 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009694
Mixed Tocopherols CA-NHP Not yet graded
CA licensed ingredient
Market presence90 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009695
Mixed Tocopherols concentrate CA-NHP Not yet graded
CA licensed ingredient
Market presence344 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009696
Mixed Tocotrienols CA-NHP Not yet graded
CA licensed ingredient
Market presence22 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009697
Mixed Tocotrienols/Tocopherols CA-NHP Not yet graded
CA licensed ingredient
Market presence31 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009698
Mixture of bifidobacteria (Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Probiotic bifidobacteria lead to a healthy intestinal flora comparable to the composition of the intestinal flora of breast-fed infants’ intestine”Non-authorisedArt.14(1)(b)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009699
MMB-CHMICA; AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1 H-indole-3-carboxamido)-3-methylbutanoate) US-CSA Not yet graded
CSA Schedule I
also: MMB-CHMICA; AMB-CHMICA -1 H-indole-3-carboxamido)-3-methylbutanoate)
Class as recordedDEA: hallucinogen / synthetic cannabinoid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-009700
MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate) US-CSA Not yet graded
CSA Schedule I
also: MMB-FUBICA -1H-indole-3-carboxamido)-3-methyl butanoate)
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other namesMMB-FUBICA
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-009701
Mobocertinib EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnUS: bulk ingredient
Class as recordedL01EB
Earliest US approval2021
Market presence1 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009702
Mockernut US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009703
Modafinil ETALYNUS-CSAUS-DRUG A/supportedband 1
CSA Schedule IVUS: anda
Class as recordedCentral Nervous System Stimulation [PE]; DEA: stimulant; Increased Sympathetic Activity [PE]; Sympathomimetic-like Agent [EPC]
Earliest US approval1998
Market presence76 US product listings · 14 FDA applications
DEA other namesProvigil
Recorded fromUS-CSA, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009704
Modified citrus pectin CA-NHP Not yet graded
CA licensed ingredient
Market presence157 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009705
modified live bovine viral diarrhoea virus type 1 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009706
modified live porcine respiratory and reproductive syndrome virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009707
modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BX
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009708
Moexipril Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]
Earliest US approval1995
Market presence7 US product listings · 10 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009709
Mogamulizumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAntibodies; Chemokine Receptor Type 4 Interaction [EPC]; Chemokine Receptor Type 4 Interactions [MoA]; L01XC25
Market presence5 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009710
Mogamulizumab-Kpkc US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009711
Moghania philippinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009712
molidustat sodium EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009713
Molindone Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedTypical Antipsychotic [EPC]
Earliest US approval1974
Market presence4 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009714
Mollusk Meat Blend CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009715
Molnupiravir EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnUS: bulk ingredient
Class as recordedJ05A
Market presence12 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009716
Molybdenum CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 1 authorised / 1 refusedCA licensed ingredientUS: unapproved drug other
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]
Market presence52 US product listings · 3,844 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Molybdenum contributes to normal sulphur amino acid metabolism”AuthorisedArt.13(1)EFSA opinion
“-Antioxidant. -Protects cells from ageing. -Important for nitrogen metabolism.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM, US-DRUG — 3 of 7 registers
Etalyn identifierETA-C-009717
Molybdenum metallicum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009718
Molybdenum MO-99 US-DRUG Not yet graded
US: drug for further processing
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009719
Molybdenum Trichloride US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009720
Momelotinib US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009721
Momelotinib Dihydrochloride EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]
Earliest US approval2023
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009722
Mometasone EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedAdrenergic beta2-Agonists [MoA]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Decreased Histamine Release [PE]
Earliest US approval1987
Market presence107 US product listings · 35 FDA applications · 7 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009723
Momordica balsamina CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009724
Momordica Balsamina Immature Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Anti-coagulant [EPC]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009725
Momordica Balsamina Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009726
Momordica charantia CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Cucumis argyi H.Lév.
Market presence309 Canadian licensed products
Parts in scopeFruits (berries); Leaves
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-009727
Momordica charantia (Common Name : balsam pear, bitter melon, bitter gourd, ampalaya, karela (karola), fu kwa) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Helps to maintain a normal blood glucose”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009729
Momordica Charantia Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009728
Momordica Charantia Stem US-DRUG Not yet graded
US: unapproved drug other
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009730
Momordica Charantia Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fungal Proteins [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009731
Momordica cochinchinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence16 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009732
Momordica grosvenorii CA-NHPEU-NOVEL Not yet graded
Novel, not yet authorisedCA licensed ingredient
Market presence2 Canadian licensed products
Parts in scopeFruits
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-009733
Monacolin K in SYLVAN BIO red yeast rice EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Monacolin K from red yeast rice contributes to the maintenance of normal blood LDL-cholesterol concentrations”Non-authorisedArt.13(5)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009734
Monalizumab US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009735
Monarda didyma EU-NOVEL Not yet graded
Not novel in food
also: Monarda coccinea Michx.
Parts in scopeInfusion of flowers; Aerial parts
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-009736
Monarda fistulosa CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009737
Monardella Odoratissima Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009738
Monascus albidus EU-NOVEL Not yet graded
Status not stated
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-009739
Monascus anka EU-NOVEL Not yet graded
Status not stated
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-009740
Monascus araneosus EU-NOVEL Not yet graded
Status not stated
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-009741
Monascus major EU-NOVEL Not yet graded
Status not stated
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-009742
Monascus pilosus-fermented Oryza sativa CA-NHP Not yet graded
CA licensed ingredient
Market presence16 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009743
Monascus purpurea-fermented Oryza sativa CA-NHP Not yet graded
CA licensed ingredient
Market presence130 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009744
Monascus purpureous (red yeast rice) EU-CLAIM Not yet graded
EU claims 0 authorised / 0 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Monacolin K from red yeast rice contributes to the maintenance of normal blood cholesterol levels · Following the amendment of Annex III of Regulation (EC) 1925/2006 as regards monacolins from red yeast rice, by which monacolins have been placed in Part B of Annex III, under ‘Restricted substances', the use of monacolins from red yeast rice at levels of 3mg and more per portion of the product recommended for daily…”RevokedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009745
Monascus Purpureus CA-NHPEU-NOVELUS-DRUG Not yet graded
Not novel in supplementsCA licensed ingredientUS: unapproved homeopathic
also: Monascus anka, Monascus araneosus, Monascus major, Monascus rubiginosus, Monascus vini
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Nitrate Vasodilator [EPC]
Market presence1 US product listings · 8 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL, US-DRUG — 3 of 7 registers
Etalyn identifierETA-C-009746
Monascus rubiginosus EU-NOVEL Not yet graded
Status not stated
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-009747
Monascus vini EU-NOVEL Not yet graded
Status not stated
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-009748
Monazite CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009749
monensin (as monensin sodium) EU-MED Not yet graded
EU medicine: Suspended
Class as recordedQA16QA06
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009750
monepantel EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009751
Monetaria moneta CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009752
Monobasic sodium phosphate CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: anda
Class as recordedCalculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
Market presence19 US product listings · 1 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009753
Monobenzone US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1952
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009754
Monoctanoin US-DRUG Not yet graded
Earliest US approval1985
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009755
Monoethanolamine Thioglycolate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009756
Monomethyl Fumarate US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2020
Market presence4 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009757
Monométhylsilanetriol: other substance with nutritionnal or physiological effects EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Contributes to maintenance of healthy skin, joints and bone. -Contributes to maintenance of strong hairs and nails. -Contributes to the structure of blood vessels. -Supports mobility and flexibility by contribution to the structure of articular cartilage”Non-authorisedArt.13(1)EFSA opinion
“Contributes to maintenance of healthy skin, joints and bone. -Contributes to maintenance of strong hairs and nails. -Contributes to the structure of blood vessels. -Supports mobility and flexibility by contribution to the structure of articular cartilage”Non-authorisedArt.13(1)EFSA opinion
“Contributes to maintenance of healthy skin, joints and bone. -Contributes to maintenance of strong hairs and nails. -Contributes to the structure of blood vessels. -Supports mobility and flexibility by contribution to the structure of articular cartilage”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009758
Mononucleosis CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009759
Monophosphothiamine US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009760
Monosodium Glutamate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Animal Fur [CS]; Bee Venoms [CS]; Catecholamine [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009762
Monosodium orthophosphate CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009763
Monosodium Phosphate CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009761
Monostroma nitidum EU-NOVEL Not yet graded
Not novel in food
also: Porphyra crispata Kjellman 1897
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-009764
Monounsatu-rated fatty acids (mainly oleic acid) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Replacement saturated fatty acids by monounsaturated fatty acids in the diet is beneficial for the blood total cholesterol, LDL cholesterol and triglyceride levels.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009765
Monounsaturated and/or polyunsaturated fatty acids EU-CLAIM Not yet graded
EU claims 2 authorised / 0 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Replacing saturated fats with unsaturated fats in the diet has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease”AuthorisedArt.14(1)(a)EFSA opinion
“Replacing saturated fats with unsaturated fats in the diet contributes to the maintenance of normal blood cholesterol levels [MUFA and PUFA are unsaturated fats]”AuthorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009766
Monounsaturated fatty acids CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence1 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Replacement saturated fatty acids by monounsaturated fatty acids in the diet is beneficial for the blood total cholesterol, LDL cholesterol and triglyceride levels.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM — 2 of 7 registers
Etalyn identifierETA-C-009767
Montelukast US-DRUG Not yet graded
US: anda
Class as recordedLeukotriene Receptor Antagonist [EPC]; Leukotriene Receptor Antagonists [MoA]
Earliest US approval1998
Market presence116 US product listings · 52 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009768
Montelukast Alcohol US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009769
Montmorillonite CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009770
Monurelle® EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Proanthocyanidins from Monurelle® may help to support defence against bacterial pathogens in the lower urinary tract”Non-authorisedArt.13(5)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009771
Moramide-intermediate US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-009772
Morantel Tartrate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009773
Moraxella Catarrhalis Subsp. Catarrhalis US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009774
Morbilinum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009775
Morbillinum CA-NHP Not yet graded
CA licensed ingredient
Market presence33 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009776
Morella cerifera CA-NHP Not yet graded
CA licensed ingredient
Market presence17 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009777
Morella Cerifera Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009778
Morella Cerifera Root Bark US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Copper [CS]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009779
Moricizine Hydrochloride US-DRUG Not yet graded
Earliest US approval1990
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009780
Morinaga Bifidobacterium longum BB536 EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Bifidobacterium longum BB536 is a probiotic that promotes bowel regularity”Non-authorisedArt.13(1)EFSA opinion
“Bifidobacterium longum BB536 is a probiotic that supports the immune system Clarification provided Bifidobacterium longum BB536 is a probiotic that supports the immune system by helping the body's natural resistance to allergens”Non-authorisedArt.13(1)EFSA opinion
““Bifidobacterium longum BB536 is a probiotic that promotes a healthy balance of intestinal bacteria” “Bifidobacterium longum BB536 is a probiotic that suppresses the growth of harmful intestinal bacteria””Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009781
Morinda citrifolia CA-NHP Not yet graded
CA licensed ingredient
Market presence151 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009782
Morinda Citrifolia Fruit US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAdenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009783
Morinda officinalis CA-NHP Not yet graded
CA licensed ingredient
Market presence166 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009784
Morinda Officinalis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009785
Moringa oleifera CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Guilandina moringa L.
Market presence689 Canadian licensed products
Parts in scopeLeaves, fruits (pods/capsule containing the seeds) and seeds; Seed oil
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-009786
Moringa Oleifera Seed Oil US-DRUG Not yet graded
US: otc monograph drug
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009787
Moringa Oleifera Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009788
moroctocog alfa EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB02BD02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009789
Morpheridine US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-009790
Morphine US-CSAUS-DRUG Not yet graded
CSA Schedule IInarcoticUS: anda
Class as recordedDEA: narcotic / opioid; Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
Earliest US approval1984
Market presence164 US product listings · 77 FDA applications
DEA other namesMS Contin; Roxanol; Oramorph; RMS; MSIR
Recorded fromUS-CSA, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009791
Morphine combination product/50 mg/ US-CSA Not yet graded
CSA Schedule IIInarcotic
Class as recordedDEA: narcotic / opioid
DEA other names100 ml or 100 gm
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-009792
Morphine methylbromide US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-009793
Morphine methylsulfonate US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-009794
Morphine-N-oxide US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-009795
Morus CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009796
Morus alba CA-NHPEU-NOVELUS-DRUG Not yet graded
Not novel in foodCA licensed ingredientUS: unapproved homeopathic
also: White Mulberry; Morus alba f. alba
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Allergens [Chemical/Ingredient]
Market presence5 US product listings · 711 Canadian licensed products
Parts in scopeFruit; Young leaves, stem and rhizome (root bark)
Recorded fromCA-NHP, EU-NOVEL, US-DRUG — 3 of 7 registers
Etalyn identifierETA-C-009797
Morus Alba Leaf US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009798
Morus Alba Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Catecholamine [EPC]
Market presence45 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009799
Morus nigra EU-NOVEL Not yet graded
Not novel in food
also: Black mulberry; Morus cretica Raf.
Parts in scopeFruit; Leaves, leaf bud, stem and root bark
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-009800
Morus Rubra Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence35 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009801
Morus Rubra Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009802
Moschus CA-NHP Not yet graded
CA licensed ingredient
Market presence27 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009803
Moschus Artifactus CA-NHP Not yet graded
CA licensed ingredient
Market presence19 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009804
Moschus artifcatus CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009805
Moschus berezovskii CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009806
Moschus moschiferus CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009807
Moschus Moschiferus Musk SAC Resin US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Analogs/Derivatives [Chemical/Ingredient]
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009808
Moschus Moschiferus Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Antimalarial [EPC]; Bee Venoms [CS]; Cell-mediated Immunity [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009809
Moschus sifanicus CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009810
Mosla chinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence43 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009811
Mosunetuzumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedL01FX25
Market presence6 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009812
Mosunetuzumab-Axgb US-DRUG Not yet graded
Earliest US approval2022
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009813
Motixafortide US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2023
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009814
Moxalactam Disodium US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009815
moxetumomab pasudotox EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedL01X
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009816
Moxetumomab Pasudotox-Tdfk US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009817
Moxidectin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Earliest US approval2018
Market presence20 US product listings · 1 FDA applications · 5 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-009818
Moxifloxacin US-DRUG Not yet graded
US: anda
Class as recordedFluoroquinolone Antibacterial [EPC]; Fluoroquinolones [CS]; Quinolone Antimicrobial [EPC]; Quinolones [CS]
Earliest US approval1999
Market presence77 US product listings · 32 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009819
mozafancogene autotemcel EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009820
MSM CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009821
MSM - methylsulfonylmetan EU-CLAIM Not yet graded
EU claims 0 authorised / 5 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Helps to improve regeneration and nutrition of cartilage”Non-authorisedArt.13(1)EFSA opinion
“MSM is important for the immune system”Non-authorisedArt.13(1)EFSA opinion
“MSM might support the healthy development and function of stomach, positively affect digestion, might also rejuvenate the peristaltics of intestines”Non-authorisedArt.13(1)EFSA opinion
“MSM supports the synthesis of metion and cystein, might have a detoxication effects”Non-authorisedArt.13(1)EFSA opinion
“supports control of organism pH balance”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009822
MSM - Methylsulfonylmethan EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“MSM nourishes joints and helps in synthesis of collagen in joint cartilage. It has positive effect on teeth, nails, hair and bones.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009823
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) US-CSA Not yet graded
CSA Schedule Inarcotic
also: MT-45 piperazine)
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-009824
Mucins CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009826
Mucopolysaccharides EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Mucopolysaccharides help maintaining healthy joints”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009827
Mucor Circinelloides US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antigens
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009828
Mucor Circinelloides F. Circinelloides US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009829
Mucor Circinelloides F. Lusitanicus US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009830
Mucor mucedo CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009831
Mucor Plumbeus US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antigens
Market presence33 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009832
Mucor Racemosus US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Antigens
Market presence34 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009833
Mucor racemosus e volumine cellulae CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009834
Mucosa nasalis suis CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009835
Mucotoxin CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009836
Mucuna pruriens CA-NHP Not yet graded
CA licensed ingredient
Market presence206 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009837
Mucuna pruriens (L.) DC EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeseeds and roots
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-009838
Mucuna Pruriens Fruit Trichome US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Bee Venoms [CS]; Cell-mediated Immunity [PE]
Market presence31 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009839
Mucuna Pruriens Seed US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009840
Muira puama CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009841
Multi-anthocyanidins CA-NHP Not yet graded
CA licensed ingredient
Market presence39 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009842
Mumomega®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Mumomega® provides the nourishments that support healthy central nervous system development.”Non-authorisedArt.14(1)(b)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009843
mumps EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BD54
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009844
Mumps Virus US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Allergens [CS]; Amide Local Anesthetic [EPC]; Amides [CS]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009845
mumps virus Jeryl Lynn (level B) strain (live, attenuated) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BD52
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009846
Mumps Virus Strain B Level Jeryl Lynn Live Antigen US-DRUG Not yet graded
US: bla
Class as recordedActively Acquired Immunity [PE]; Attenuated [CS]; Chickenpox Vaccine [CS]; Herpes Zoster Vaccine [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009847
Mung bean (Vigna Radiata) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Phytoestrogens are commonly used by women who cannot / do not want to use HRT during menopause. PB is a source of phytoestrogens. PB is a source of oestrogenic support during menopause and beyond. Oestrogenic support during menopause years and beyond which helps maintain wellbeing and quality of life.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009848
Mupirocin US-DRUG Not yet graded
US: anda
Class as recordedRNA Synthetase Inhibitor Antibacterial [EPC]; RNA Synthetase Inhibitors [MoA]
Earliest US approval1987
Market presence56 US product listings · 16 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009849
Murex purpurea CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009850
Muriaticum acidum CA-NHP Not yet graded
CA licensed ingredient
Market presence26 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009851
Murraya paniculata CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009852
MUS Musculus Hair US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Animal Fur [CS]; Cell-mediated Immunity [PE]; Cells
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009853
MUS Musculus Skin US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Animal Fur [CS]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009854
Musa acuminata CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: dwarf banana; Cavendish banana; Musa simiarum Kurz; dwarf sweet banana
Market presence3 Canadian licensed products
Parts in scopeFruit (berry)
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-009855
Musa Acuminata Fruit US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009856